Literature DB >> 28624465

Muscle pathology in Vici syndrome-A case study with a novel mutation in EPG5 and a summary of the literature.

Carola Hedberg-Oldfors1, Niklas Darin2, Anders Oldfors3.   

Abstract

Vici syndrome is a disorder characterized by myopathy, cardiomyopathy, agenesis of the corpus callosum, immunodeficiency, cataracts, hypopigmentation, microcephaly, gross developmental delay and failure to thrive. It is caused by mutations in EPG5, which encodes a protein involved in the autophagy pathway. Although myopathy is part of the syndrome, few publications have described the muscle pathology. We present a detailed morphological analysis in a boy with Vici syndrome due to a novel homozygous one-base deletion in EPG5 (c.784delA), and we review the histopathological findings from previous reports. Muscle biopsy was performed at three months of age and demonstrated small vacuolated fibers, frequently with internal nuclei, and expressing developmental and fast myosin isoforms. There was an increase in acid phosphatase activity in the small fibers, which also showed LAMP-2 upregulation, glycogen accumulation and contained numerous p62-positive inclusions and some lipid droplets. Electron microscopy demonstrated hypoplastic fibers with massive glycogen accumulation and extensive disorganization of the myofibrils. This study expands the muscle pathological features of Vici syndrome and demonstrates a pattern of vacuolar myopathy with glycogen storage and immature, hypoplastic and atrophic muscle fibers. Increased lysosomes and accumulation of p62 are in line with a disturbance of the autophagic pathway as an essential part of the pathogenesis.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Autophagy; EPG5; Lysosome; Muscle pathology; Vacuolar myopathy; Vici syndrome

Mesh:

Substances:

Year:  2017        PMID: 28624465     DOI: 10.1016/j.nmd.2017.05.005

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  6 in total

1.  Novel EPG5 Mutation Associated with Vici Syndrome Gene.

Authors:  Frouzandeh Mahjoubi; Samira Shabani; Sogand Khakbazpour; Aylar Khaligh Akhlaghi
Journal:  Case Rep Genet       Date:  2022-07-05

2.  Human platelets display dysregulated sepsis-associated autophagy, induced by altered LC3 protein-protein interaction of the Vici-protein EPG5.

Authors:  Hansjörg Schwertz; Jesse W Rowley; Irina Portier; Elizabeth A Middleton; Neal D Tolley; Robert A Campbell; Alicia S Eustes; Karin Chen; Matthew T Rondina
Journal:  Autophagy       Date:  2021-11-18       Impact factor: 13.391

3.  EPG5-Related Vici Syndrome: A Primary Defect of Autophagic Regulation with an Emerging Phenotype Overlapping with Mitochondrial Disorders.

Authors:  Shanti Balasubramaniam; Lisa G Riley; Anand Vasudevan; Mark J Cowley; Velimir Gayevskiy; Carolyn M Sue; Caitlin Edwards; Edward Edkins; Reimar Junckerstorff; C Kiraly-Borri; P Rowe; J Christodoulou
Journal:  JIMD Rep       Date:  2017-11-21

4.  A Saudi Infant with Vici Syndrome: Case Report and Literature Review.

Authors:  Alhussain Alzahrani; Abdulrahman Abdullah Alghamdi; Rahaf Waggass
Journal:  Open Access Maced J Med Sci       Date:  2018-06-13

5.  Effectiveness of whole exome sequencing in unsolved patients with a clinical suspicion of a mitochondrial disorder in Estonia.

Authors:  Sanna Puusepp; Karit Reinson; Sander Pajusalu; Ülle Murumets; Eve Õiglane-Shlik; Reet Rein; Inga Talvik; Richard J Rodenburg; Katrin Õunap
Journal:  Mol Genet Metab Rep       Date:  2018-03-15

Review 6.  Vici syndrome with pathogenic homozygous EPG5 gene mutation: A case report and literature review.

Authors:  Kamal T Abidi; Naglaa M Kamal; Ayman A Bakkar; Saad Almarri; Rehab Abdullah; Maram Alsufyani; Arwa Alharbi
Journal:  Medicine (Baltimore)       Date:  2020-10-23       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.